Julie Gould

Integrated Healthcare Executive
How AI Use Impacts the Entire Care Team
01/27/2020
Emad Rizk, MD, president and CEO of Cotiviti, highlights the implications of artificial intelligence (AI) that he recently discussed with Congress and the White House Office of Science and Technology Policy and also explains ways AI will...
Emad Rizk, MD, president and CEO of Cotiviti, highlights the implications of artificial intelligence (AI) that he recently discussed with Congress and the White House Office of Science and Technology Policy and also explains ways AI will...
Emad Rizk, MD, president and CEO...
01/27/2020
First Report Managed Care
News
Study Reports Positive Patient Response to Oral Treatment for Atopic Dermatitis
08/27/2021
“Oral abrocitinib in combination with topical therapy was effective and well-tolerated in adolescents with moderate-to-severe atopic dermatitis,” explained study authors.
“Oral abrocitinib in combination with topical therapy was effective and well-tolerated in adolescents with moderate-to-severe atopic dermatitis,” explained study authors.
“Oral abrocitinib in combination...
08/27/2021
First Report Managed Care
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Hospital Drug Spending Trends During the COVID-19 Pandemic
08/09/2021
Eric Tichy, PharmD, MBA, vice chair, Mayo Clinic, discusses a Mayo Clinic report on drug spending during the COVID-19 pandemic, highlighting which drugs saw dramatic increases or decreases in spending, as well as how providers can use...
Eric Tichy, PharmD, MBA, vice chair, Mayo Clinic, discusses a Mayo Clinic report on drug spending during the COVID-19 pandemic, highlighting which drugs saw dramatic increases or decreases in spending, as well as how providers can use...
Eric Tichy, PharmD, MBA, vice...
08/09/2021
Pharmacy Learning Network
lawrence green MD
Podcasts
The Future of Sun Protection, Inclusivity in Dermatology, and the Impact of the Environment on Skin
03/27/2022
During AAD 2022, The Dermatologist met with Lawrence Green, MD, who reviewed the future of sun protection for patients, how the AAD is working to expand inclusivity in the field of dermatology, and finally reviewed the impact the environment...
During AAD 2022, The Dermatologist met with Lawrence Green, MD, who reviewed the future of sun protection for patients, how the AAD is working to expand inclusivity in the field of dermatology, and finally reviewed the impact the environment...
During AAD 2022, The...
03/27/2022
The Dermatologist
News
How Vitamin D Is Linked to Periodontal Health
08/31/2023
“This review aims to first examine the biological mechanisms by which vitamin D might influence the pathogenesis of periodontal disease and second, discuss the clinical evidence which implicate the role of vitamin D in periodontal disease,”...
“This review aims to first examine the biological mechanisms by which vitamin D might influence the pathogenesis of periodontal disease and second, discuss the clinical evidence which implicate the role of vitamin D in periodontal disease,”...
“This review aims to first...
08/31/2023
Dentistry
News
Using Socioeconomic, Insurance Status to Help Identify Risk Factors for Uncontrolled Asthma in a US Cohort
09/20/2023
"Socioeconomic and insurance status, asthma severity, and prior health care utilization have been shown to predict the risk of hospitalization, in the US," explained authors. "Thus, identifying patients who are at the higher risk for...
"Socioeconomic and insurance status, asthma severity, and prior health care utilization have been shown to predict the risk of hospitalization, in the US," explained authors. "Thus, identifying patients who are at the higher risk for...
"Socioeconomic and insurance...
09/20/2023
First Report Managed Care
Literature Review
Regulating the Use of CAR-T Therapy Outside of the Drug Paradigm
10/23/2020
Currently, chimeric antigen receptor T-cell (CAR-T) therapies are regulated as drugs—often leading to higher prices and barriers to access for patients, as well as financial strains for hospitals. However, in a recent insights article in JAMA...
Currently, chimeric antigen receptor T-cell (CAR-T) therapies are regulated as drugs—often leading to higher prices and barriers to access for patients, as well as financial strains for hospitals. However, in a recent insights article in JAMA...
Currently, chimeric antigen...
10/23/2020
First Report Managed Care
Managed Care Q&A
Using Digital Health Management Platforms to Connect With Members, Improve Care
05/28/2021
Sandhya Gardner, MD, chief medical officer at Wellframe, shares insight from a recent survey about plan member engagement, discusses care management and coordination via digital health tools, and explains how the pandemic has shed light on...
Sandhya Gardner, MD, chief medical officer at Wellframe, shares insight from a recent survey about plan member engagement, discusses care management and coordination via digital health tools, and explains how the pandemic has shed light on...
Sandhya Gardner, MD, chief...
05/28/2021
First Report Managed Care
Conference Coverage
Understanding Demographics, Clinical Characteristics Among Patients Receiving Anti-obesity Medications
10/20/2021
Analysis findings presented during AMCP Nexus 2021 showed suggested patients treated with anti-obesity medications have obesity-related comorbidities; however, patients who initiated an older generation anti-obesity medication had a higher...
Analysis findings presented during AMCP Nexus 2021 showed suggested patients treated with anti-obesity medications have obesity-related comorbidities; however, patients who initiated an older generation anti-obesity medication had a higher...
Analysis findings presented...
10/20/2021
Pharmacy Learning Network
psoriasis on neck
Conference Coverage
Improved Skin Clearance Observed Among Patients With Psoriasis Treated With Combo Therapy
03/26/2022
Research from the AAD annual meeting showed that clinical responses were maintained at week 96 for patients treated with secukinumab followed by bimekizumab.
Research from the AAD annual meeting showed that clinical responses were maintained at week 96 for patients treated with secukinumab followed by bimekizumab.
Research from the AAD annual...
03/26/2022
The Dermatologist

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use